by gopharmazie | May 9, 2025 | Drug Pricing
Drug pricing database Germany – these four words sum up a critical need in the pharmaceutical industry. In a market as regulated and dynamic as Germany’s, professionals across market access, pharmacovigilance, hospital pharmacy, and health insurance face the constant...
by gopharmazie | May 9, 2025 | Drug Pricing
Pharmaceutical pricing in Germany is unique in Europe – offering initial free pricing yet governed by strict mechanisms like AMNOG benefit assessments, reference pricing, and rebate contracts. In this comprehensive guide, we explain pharma pricing in Germany for...
by gopharmazie | May 9, 2025 | Drug Dictionaries
Access to an accurate, up-to-date European drug pricing database is essential for healthcare professionals in Germany, Austria, and Switzerland. Whether you’re calculating reimbursement, comparing market prices, or sourcing alternatives during shortages, having...
by gopharmazie | May 9, 2025 | Drug Pricing
Pharmaceutical market access in Germany is a critical step for any drug developer aiming to tap into Europe’s largest pharmaceutical market. With a population of 84 million and annual pharmaceutical revenues exceeding €56.9 billion in 2021, Germany offers vast...
by gopharmazie | May 21, 2019 | Most popular
IFA Pharmaceuticals and their way into pharmaceutical databases How does the IFA medicines information get from the ABDA article master to pharmaceutical databases like pharmazie.com? This question is answered in the following article. You will learn who the IFA is,...
